Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.
A three-person arbitration panel overseen by Finra Dispute Resolution Services stunned the financial advice industry on ...
Detailed price information for The Beauty Health Co. (SKIN-Q) from The Globe and Mail including charting and trades.
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...
Stifel Nicolaus initiated coverage on shares of Uranium Energy (NYSEAMERICAN:UEC – Free Report) in a report issued on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating on the basic ...
Stifel Nicolaus analyst Jeffrey Stantial reiterated a Buy rating on Vail Resorts (MTN – Research Report) today and set a price target of $217.00. The company’s shares opened t ...
Siegmann Brings Extensive Industry & Investment Experience to StifelST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing ...
Oracle (NYSE:ORCL – Free Report) had its price objective lowered by Stifel Nicolaus from $175.00 to $150.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus ...
For the second time in about two weeks, a FINRA arbitration panel has cited state statutes to slap a wealth management firm ...
Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...